Presentation Information

[P04-525]Application of Large-Pore Cellulose Chromatography Media: Cellufine MLP for High-Performance Viral Vector and Vaccine Purification

○Junya Toba1, Ayana Uehara1, Chigusa Mori1, Yoshihiro Matsumoto1, Eri Iwamoto1 (1. JNC corporation (Japan))
PDF DownloadDownload PDF

Keywords:

Chromatography,Viral vector,Biopharmaceuticals,Porous particle,Convective transport

[Purpose]
The aim was to develop chromatography media capable of efficiently purifying large biomolecules, such as viral vectors and whole virus vaccines, which are increasingly important in biotherapeutic applications.
[Method]
We created Cellufine MLPTM, a new class of permeable cellulose beads with continuous pore structures over 1 μm within 90 μm spherical particles. These beads were evaluated for purification of large biomolecules using application studies with inactivated vaccine and gene therapy vectors.
[Results]
Cellufine MLPTM demonstrated high binding capacity, improved recovery, and enhanced impurity removal compared to conventional media. The unique large-pore architecture enabled efficient capture and processing of virus-sized particles.
[Consideration]
The observed improvements in binding capacity and impurity removal can be attributed to the continuous large-pore structure of Cellufine MLPTM beads, which facilitates convective transport within the particle interior. This architectural feature mitigates the diffusional limitations typically associated with conventional chromatography media, allowing for more effective processing of virus-sized biomolecules.
[Conclusion]
These findings suggest that the transition from diffusion-dominated to convection-dominated transport enabled by the large-pore cellulose matrix offers clear advantages for the purification of large biomolecules. Cellufine MLPTM may contribute to improved process efficiency and scalability in biotherapeutic manufacturing, particularly in the context of viral vectors, vaccines, and similarly sized modalities.

Comment

To browse or post comments, you must log in.Log in